UMBRELLA PLUS - molecular-driven treatments for kidney cancer
Improving genetic testing for children with kidney cancers like Wilms tumour and finding a way to improve diagnosis and relapse monitoring.
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Improving genetic testing for children with kidney cancers like Wilms tumour and finding a way to improve diagnosis and relapse monitoring.
Investigating a new theory for how kidney cancer grows and spreads.
Investigating a protein found on leukaemia stem cells, the cells which cause relapse, and whether it could be a good drug target.
Looking at whether a pre-existing drug could be an effective and safe treatment due to its ability to target cancer cells directly.
Understanding how hepatocellular carcinoma develops and what role the immune system plays.
Investigating how different levels short non-coding RNAs affect germ cell tumour cells, and testing whether medicines altering these levels could be a potential treatment.
Creating a new immunotherapy that will attacks collagen in cancer cells, and testing whether it is effective in model systems to make it the best it can be.
Understanding how the MYCN protein changes the amounts of other proteins in the cell by changing the way DNA is processed and translated.
Investigating cancer stem cells in Wilms tumour to see whether they are responsible for relapse, and to understand how that happens.